Event Type: The management of Suven Life Sciences Limited will be meeting with investors and analysts in both group and one-on-one formats as an "Interaction with Investors & Analysts".
Date and Time: The meeting is scheduled for July 17, 2026. The specific time was not disclosed in the announcement.
Location and Mode: The meeting will be held in Mumbai and will be conducted in-person.
Purpose: The purpose is for interaction with investors and analysts, though no specific discussion topics (such as quarterly results) are mentioned.
Management Participants: The announcement does not specify which management members will be participating in the meeting.
Presentation Materials: The document does not indicate whether any presentation, earnings deck, transcript, or recording will be made available.
UPSI Compliance: The company explicitly states that "No unpublished price-sensitive information will be shared during this interaction."
Financial Data: No financial highlights, guidance references, or presentation summaries were included in this disclosure.
Additional Notes Section
This is a regulatory intimation made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company notes that the schedule is "subject to change by the Investors/the Company."
No financial data or performance figures were disclosed in this announcement.
The document was digitally signed by Kandari Sangeetha Laxmi, Company Secretary and Compliance officer, on July 14, 2026 at 12:02:34 IST.
